This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Haemonetics’s 8K filing here.
About Haemonetics
Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app.
Recommended Stories
- Five stocks we like better than Haemonetics
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- What Are Dividend Contenders? Investing in Dividend Contenders
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- What Are Dividend Achievers? An Introduction
- Delta Can Fly to New Highs in 2025; Here’s Why
